Table 1.
Age at diagnosis, mean (range) | 63.8 (40 – 73) |
---|---|
PSA levels at diagnosis (ng/ml) |
No. of patients |
< 4.0 |
13 (10.5%) |
4.0 – 10.0 |
75 (60.5%) |
10.1 – 20.0 |
29 (23.4%) |
20.1 – 50.0 |
6 (4.8%) |
50.1 or higher |
1 (0.8%) |
Gleason score at biopsy |
No. of patients |
6 |
48 (38.7%) |
3 + 4 |
20 (16.1%) |
4 + 3 |
20 (16.1%) |
8 or higher | 36 (29.0%) |
PSA, prostate-specific antigen.